Joshua Silverman is Director of Petros Pharmaceuticals, Inc.. Currently has a direct ownership of 11,237 shares of PTPI, which is worth approximately $4,157. The most recent transaction as insider was on Apr 26, 2023, when has been sold 6,722 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.2K
0% 3M change
0% 12M change
Total Value Held $4,157

Joshua Silverman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 26 2023
BUY
Exercise of conversion of derivative security
-
6,722 Added 37.43%
11,237 Common Stock
Jan 20 2023
BUY
Exercise of conversion of derivative security
-
2,515 Added 35.78%
4,515 Common Stock
Dec 01 2020
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock, par valu...

Also insider at

AYRO
AYRO, Inc. Consumer Cyclical
MYMD
MyMD Pharmaceuticals, Inc. Healthcare
SNPX
Synaptogenix, Inc. Healthcare
FEMY
FEMASYS INC Healthcare
PMCB
PharmaCyte Biotech, Inc. Healthcare
JS

Joshua Silverman

Director
Round Rock, TX

Track Institutional and Insider Activities on PTPI

Follow Petros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTPI shares.

Notify only if

Insider Trading

Get notified when an Petros Pharmaceuticals, Inc. insider buys or sells PTPI shares.

Notify only if

News

Receive news related to Petros Pharmaceuticals, Inc.

Track Activities on PTPI